vs
Lakeside Holding Ltd（LSH）与PROVIDENT FINANCIAL HOLDINGS INC（PROV）财务数据对比。点击上方公司名可切换其他公司
PROVIDENT FINANCIAL HOLDINGS INC的季度营收约是Lakeside Holding Ltd的1.4倍（$9.8M vs $7.0M），PROVIDENT FINANCIAL HOLDINGS INC净利率更高（14.6% vs -22.6%，领先37.2%），Lakeside Holding Ltd同比增速更快（95.0% vs 2.5%）
莱克赛德出版社是位于美国芝加哥的出版品牌，由RR唐纳利公司运营。该社除了出版高品质书籍外，还承印邮购目录、电话号码簿、百科全书与广告宣传品，最为人熟知的是为芝加哥卡克斯顿俱乐部出版的高端版本，以及经典重印丛书《莱克赛德经典》。
普罗维登特金融控股公司是一家银行控股企业，通过旗下全资子公司普罗维登特储蓄银行开展业务，为美国加利福尼亚州当地社区提供各类存款、住房抵押贷款、消费贷款、小微企业融资等零售及商业金融服务。
LSH vs PROV — 直观对比
营收规模更大
PROV
是对方的1.4倍
$7.0M
营收增速更快
LSH
高出92.6%
2.5%
净利率更高
PROV
高出37.2%
-22.6%
损益表 — Q4 FY2025 vs Q2 FY2026
| 指标 | | |
|---|---|---|
| 营收 | $7.0M | $9.8M |
| 净利润 | $-1.6M | $1.4M |
| 毛利率 | 27.2% | — |
| 营业利润率 | -21.3% | 20.8% |
| 净利率 | -22.6% | 14.6% |
| 营收同比 | 95.0% | 2.5% |
| 净利润同比 | 18.7% | 64.7% |
| 每股收益（稀释后） | $-0.08 | $0.22 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收LSHPROV
| Q4 25 | $7.0M | $9.8M | ||
| Q3 25 | $6.1M | $9.7M | ||
| Q2 25 | $6.3M | $9.8M | ||
| Q1 25 | $3.8M | $10.1M | ||
| Q4 24 | $3.6M | $9.6M | ||
| Q3 24 | $4.1M | $9.5M | ||
| Q2 24 | — | $9.9M | ||
| Q1 24 | — | $9.4M |
净利润LSHPROV
| Q4 25 | $-1.6M | $1.4M | ||
| Q3 25 | $-1.4M | $1.7M | ||
| Q2 25 | $-893.1K | $1.6M | ||
| Q1 25 | $-1.1M | $1.9M | ||
| Q4 24 | $-1.9M | $872.0K | ||
| Q3 24 | $-1.3M | $1.9M | ||
| Q2 24 | — | $2.0M | ||
| Q1 24 | — | $1.5M |
毛利率LSHPROV
| Q4 25 | 27.2% | — | ||
| Q3 25 | 18.2% | — | ||
| Q2 25 | 26.7% | — | ||
| Q1 25 | 18.8% | — | ||
| Q4 24 | -1.2% | — | ||
| Q3 24 | 12.8% | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
营业利润率LSHPROV
| Q4 25 | -21.3% | 20.8% | ||
| Q3 25 | -20.8% | 28.1% | ||
| Q2 25 | -8.9% | 23.6% | ||
| Q1 25 | -28.2% | 26.2% | ||
| Q4 24 | -55.6% | 12.7% | ||
| Q3 24 | -32.5% | 28.3% | ||
| Q2 24 | — | 27.8% | ||
| Q1 24 | — | 22.5% |
净利率LSHPROV
| Q4 25 | -22.6% | 14.6% | ||
| Q3 25 | -22.2% | 17.3% | ||
| Q2 25 | -14.2% | 16.7% | ||
| Q1 25 | -28.2% | 18.4% | ||
| Q4 24 | -54.1% | 9.1% | ||
| Q3 24 | -32.7% | 20.0% | ||
| Q2 24 | — | 19.7% | ||
| Q1 24 | — | 15.9% |
每股收益（稀释后）LSHPROV
| Q4 25 | $-0.08 | $0.22 | ||
| Q3 25 | $-0.09 | $0.25 | ||
| Q2 25 | $-0.11 | $0.24 | ||
| Q1 25 | $-0.14 | $0.28 | ||
| Q4 24 | $-0.26 | $0.13 | ||
| Q3 24 | $-0.18 | $0.28 | ||
| Q2 24 | — | $0.28 | ||
| Q1 24 | — | $0.22 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $1.6M | $54.4M |
| 总债务越低越好 | $2.4M | — |
| 股东权益账面价值 | $12.2M | $127.5M |
| 总资产 | $24.3M | $1.2B |
| 负债/权益比越低杠杆越低 | 0.20× | — |
8季度趋势，按日历期对齐
现金及短期投资LSHPROV
| Q4 25 | $1.6M | $54.4M | ||
| Q3 25 | $4.5M | $49.4M | ||
| Q2 25 | $5.0M | $53.1M | ||
| Q1 25 | $1.5M | $50.9M | ||
| Q4 24 | $1.1M | $45.5M | ||
| Q3 24 | $2.7M | $48.2M | ||
| Q2 24 | — | $51.4M | ||
| Q1 24 | — | $51.7M |
总债务LSHPROV
| Q4 25 | $2.4M | — | ||
| Q3 25 | $2.4M | — | ||
| Q2 25 | $1.4M | — | ||
| Q1 25 | $774.2K | — | ||
| Q4 24 | $784.8K | — | ||
| Q3 24 | $589.9K | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
股东权益LSHPROV
| Q4 25 | $12.2M | $127.5M | ||
| Q3 25 | $7.0M | $128.4M | ||
| Q2 25 | $2.8M | $128.5M | ||
| Q1 25 | $749.8K | $128.9M | ||
| Q4 24 | $1.6M | $128.6M | ||
| Q3 24 | $3.6M | $129.6M | ||
| Q2 24 | — | $129.9M | ||
| Q1 24 | — | $129.5M |
总资产LSHPROV
| Q4 25 | $24.3M | $1.2B | ||
| Q3 25 | $18.6M | $1.2B | ||
| Q2 25 | $14.4M | $1.2B | ||
| Q1 25 | $9.9M | $1.3B | ||
| Q4 24 | $9.8M | $1.3B | ||
| Q3 24 | $10.8M | $1.3B | ||
| Q2 24 | — | $1.3B | ||
| Q1 24 | — | $1.3B |
负债/权益比LSHPROV
| Q4 25 | 0.20× | — | ||
| Q3 25 | 0.35× | — | ||
| Q2 25 | 0.48× | — | ||
| Q1 25 | 1.03× | — | ||
| Q4 24 | 0.48× | — | ||
| Q3 24 | 0.16× | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-453.5K | $1.2M |
| 自由现金流经营现金流 - 资本支出 | — | $1.0M |
| 自由现金流率自由现金流/营收 | — | 10.5% |
| 资本支出强度资本支出/营收 | — | 1.9% |
| 现金转化率经营现金流/净利润 | — | 0.85× |
| 过去12个月自由现金流最近4个季度 | — | $14.9M |
8季度趋势，按日历期对齐
经营现金流LSHPROV
| Q4 25 | $-453.5K | $1.2M | ||
| Q3 25 | $-4.0M | $2.5M | ||
| Q2 25 | $-483.7K | $8.7M | ||
| Q1 25 | $-238.3K | $3.3M | ||
| Q4 24 | $-530.2K | $324.0K | ||
| Q3 24 | $-1.4M | $2.6M | ||
| Q2 24 | — | $5.7M | ||
| Q1 24 | — | $3.0M |
自由现金流LSHPROV
| Q4 25 | — | $1.0M | ||
| Q3 25 | — | $2.5M | ||
| Q2 25 | $-497.4K | $8.2M | ||
| Q1 25 | — | $3.3M | ||
| Q4 24 | $-560.5K | $307.0K | ||
| Q3 24 | $-1.4M | $2.4M | ||
| Q2 24 | — | $4.1M | ||
| Q1 24 | — | $2.6M |
自由现金流率LSHPROV
| Q4 25 | — | 10.5% | ||
| Q3 25 | — | 25.2% | ||
| Q2 25 | -7.9% | 83.5% | ||
| Q1 25 | — | 32.5% | ||
| Q4 24 | -15.6% | 3.2% | ||
| Q3 24 | -34.5% | 25.1% | ||
| Q2 24 | — | 41.3% | ||
| Q1 24 | — | 27.5% |
资本支出强度LSHPROV
| Q4 25 | — | 1.9% | ||
| Q3 25 | — | 0.5% | ||
| Q2 25 | 0.2% | 5.4% | ||
| Q1 25 | 0.0% | 0.3% | ||
| Q4 24 | 0.8% | 0.2% | ||
| Q3 24 | 0.1% | 1.8% | ||
| Q2 24 | — | 16.0% | ||
| Q1 24 | — | 4.2% |
现金转化率LSHPROV
| Q4 25 | — | 0.85× | ||
| Q3 25 | — | 1.48× | ||
| Q2 25 | — | 5.34× | ||
| Q1 25 | — | 1.79× | ||
| Q4 24 | — | 0.37× | ||
| Q3 24 | — | 1.35× | ||
| Q2 24 | — | 2.91× | ||
| Q1 24 | — | 2.00× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
LSH
| Transferred Over Time | $4.6M | 65% |
| Distribution Of Pharmaceutical Products | $2.4M | 35% |
PROV
暂无分部数据
